Jefferies Group’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $28.9M | Sell |
238,300
-214,700
| -47% | -$27.7M | 0.24% | 66 |
|
|
2022
Q2 | $58.1M | Buy |
453,000
+152,600
| +51% | +$20M | 0.48% | 30 |
|
|
2022
Q1 | $41.2M | Buy |
300,400
+250,400
| +501% | +$33.2M | 0.26% | 57 |
|
|
2021
Q4 | $7.04M | Sell |
50,000
-30,000
| -38% | -$3.98M | 0.04% | 365 |
|
|
2021
Q3 | $10.2M | Hold |
80,000
| – | – | 0.07% | 252 |
|
|
2021
Q2 | $10.1M | Sell |
80,000
-20,000
| -20% | -$2.45M | 0.06% | 272 |
|
|
2021
Q1 | $11.7M | Sell |
100,000
-195,000
| -66% | -$22.5M | 0.1% | 161 |
|
|
2020
Q4 | $33.5M | Buy |
295,000
+61,000
| +26% | +$6.66M | 0.26% | 51 |
|
|
2020
Q3 | $24.7M | Sell |
234,000
-110,500
| -32% | -$11.6M | 0.27% | 47 |
|
|
2020
Q2 | $34.5K | Sell |
344,500
-145,000
| -30% | -$14.3M | 0.41% | 29 |
|
|
2020
Q1 | $43.4M | Buy |
489,500
+164,500
| +51% | +$16M | 0.48% | 17 |
|
|
2019
Q4 | $33.1M | Sell |
325,000
-426,900
| -57% | -$41M | 0.26% | 56 |
|
|
2019
Q3 | $67.8M | Buy |
751,900
+299,000
| +66% | +$27.3M | 0.53% | 17 |
|
|
2019
Q2 | $42M | Buy |
452,900
+292,900
| +183% | +$26.3M | 0.31% | 40 |
|
|
2019
Q1 | $14.7M | Buy |
160,000
+86,500
| +118% | +$7.8M | 0.12% | 128 |
|
|
2018
Q4 | $6.36M | Buy |
73,500
+23,500
| +47% | +$2.13M | 0.05% | 324 |
|
|
2018
Q3 | $4.76M | Buy |
+50,000
| New | +$4.52M | 0.03% | 551 |
|
|
2018
Q1 | – | Sell |
-185,000
| Closed | -$15.3M | – | 2772 |
|
|
2017
Q4 | $15.3M | Buy |
185,000
+179,600
| +3,326% | +$14.8M | 0.07% | 193 |
|
|
2017
Q3 | $441K | Sell |
5,400
-171,000
| -97% | -$13.7M | ﹤0.01% | 1698 |
|
|
2017
Q2 | $14M | Sell |
176,400
-2,624,200
| -94% | -$200M | 0.09% | 191 |
|
|
2017
Q1 | $208M | Buy |
2,800,600
+1,832,300
| +189% | +$134M | 1.55% | 6 |
|
|
2016
Q4 | $66.8M | Buy |
968,300
+484,600
| +100% | +$33.6M | 0.37% | 34 |
|
|
2016
Q3 | $34.9M | Sell |
483,700
-1,435,100
| -75% | -$106M | 0.18% | 92 |
|
|
2016
Q2 | $138M | Buy |
1,918,800
+1,722,700
| +878% | +$121M | 0.63% | 17 |
|
|
2016
Q1 | $13.3M | Sell |
196,100
-413,400
| -68% | -$27.7M | 0.08% | 198 |
|
|
2015
Q4 | $43.9M | Sell |
609,500
-308,900
| -34% | -$21.8M | 0.25% | 69 |
|
|
2015
Q3 | $60.8M | Buy |
918,400
+453,900
| +98% | +$33.2M | 0.35% | 44 |
|
|
2015
Q2 | $34.6M | Buy |
+464,500
| New | +$34.4M | 0.18% | 92 |
|
|
2014
Q3 | – | Sell |
-270,000
| Closed | -$16.4M | – | 2488 |
|
|
2014
Q2 | $16.4M | Buy |
270,000
+252,400
| +1,434% | +$14.8M | 0.14% | 127 |
|
|
2014
Q1 | $1.03M | Buy |
+17,600
| New | +$1.01M | 0.01% | 905 |
|
|
2013
Q4 | – | Sell |
-400,000
| Closed | -$20.2M | – | 2261 |
|
|
2013
Q3 | $20.2M | Buy |
+400,000
| New | +$20.1M | 0.2% | 68 |
|
Other funds holding XLV
RJA
Jefferies Group's XLV Position: Q3 2022 in Review
Jefferies Group reduced its State Street Health Care Select Sector SPDR ETF (XLV) stake by 84% in Q3 2022, selling an estimated $19.4M and leaving 29,173 shares worth $3.53M. The position accounts for 0.03% of the portfolio, ranked #431.
Jefferies Group first reported a position in XLV in Q2 2013 and has held it in 37 quarters since. The position peaked at $37.3M in Q4 2016. 1,422 funds tracked by Wall St. Rank hold XLV as of Q3 2022.
- Jefferies Group held 29,173 shares of State Street Health Care Select Sector SPDR ETF worth $3.53M as of Q3 2022.
- Jefferies Group sold 150,993 State Street Health Care Select Sector SPDR ETF shares in Q3 2022, an estimated $19.4M.
- State Street Health Care Select Sector SPDR ETF made up 0.03% of Jefferies Group's portfolio in Q3 2022, its #431 holding.
- Jefferies Group first reported a position in State Street Health Care Select Sector SPDR ETF in Q2 2013 and has held it in 37 quarters since.
- Jefferies Group's State Street Health Care Select Sector SPDR ETF position peaked at $37.3M in Q4 2016.
- 1,422 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q3 2022.
Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.